BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30

• Biotech Beach

  Agena Bioscience’s Liquid Biopsy Technology Awarded Horizon 2020 Grant by European Union

  Agena Biosciences today announced it has been selected to participate as an innovative technology provider in the LIMA project.

  November 30, 2017

   · 

  2 min read
• Pharm Country

  Applied DNA Expands BioPharm Vertical With Two New Research Pilots of DNA Therapeutics

  These pilots will be developed using the Company’s proprietary and patented large-scale PCR (polymerase chain reaction) DNA production processes and devices.

  November 30, 2017

   · 

  8 min read
• Sinovac Biotech Announces Update on Nasdaq Matters

  Sinovac announced today that the Nasdaq Hearings Panel granted the Company’s request to extend the stay of suspension in trading of the Company’s common shares pending a hearing on January 11, 2018 and issuance of a final Panel decision.

  November 30, 2017

   · 

  2 min read
• Biotech Beach

  Senomyx Regains Compliance With Nasdaq Minimum Bid Price Listing Requirement

  Accordingly, the Company has regained compliance with Nasdaq Listing Rule 5450(a)(1) and Nasdaq considers the matter closed.

  November 30, 2017

   · 

  1 min read
• Pharm Country

  Soligenix to Receive $417,000 in Non-Dilutive Funding Through New Jersey Technology Business Tax Certificate Transfer Program

  Soligenix announced today that it has received preliminary approval for a tax credit from the NJEDA’s New Jersey Technology Business Tax Certificate Transfer program.

  November 30, 2017

   · 

  5 min read
• Business

  Merrimack Announces Appointment of George Demetri, M.D., to Board of Directors

  Dr. Demetri, a world-renowned expert in the clinical translation of innovative treatment strategies for cancer, replaces John Mendelsohn, M.D., who is retiring from the Board.

  November 30, 2017

   · 

  3 min read
• Drug Development

  ArmaGen’s AGT-181 Granted Fast Track Designation for the Treatment of Hurler Syndrome (MPS I)

  The data suggested that AGT-181 improves neurocognitive function in patients with MPS I, demonstrating the ability of ArmaGen’s proprietary drug delivery technology to transport biopharmaceuticals across the blood-brain barrier.

  November 30, 2017

   · 

  3 min read
• Business

  Fractyl Appoints Senator William W. Bradley and Dr. John Amatruda to the Company’s Board of Directors

  Fractyl today announced the appointment of Senator William W. Bradley and Dr. John Amatruda to the company’s board of directors.

  November 30, 2017

   · 

  3 min read
• 

  Genetown

  Massachusetts’ Fractyl Bags $44M to Advance New Treatment for Type 2 Diabetes

  Proceeds from the financing will be used towards continued development of Fractyl’s Revita DMR technology for patients with type 2 diabetes.

  November 30, 2017

   · 

  3 min read
• Business

  Oncolytics Biotech Establishes Scientific Advisory Board Focused on REOLYSIN Registration Study in Metastatic Breast Cancer

  The SAB will provide Oncolytics with significant clinical expertise and experience in breast cancer drug development in both the U.S. and Europe.

  November 30, 2017

   · 

  6 min read